Software Co. Combines AI and Wearables For Glucose Monitoring

Artificial Intelligence (AI), wearables, and diabetes monitoring are arguably three of the hottest sectors in medtech at the moment. LifePlus, a small software startup, has the distinction of belonging to all three markets. The Menlo, CA-based company is developing LifeLeaf, a non-invasive continuous blood glucose monitoring (CGM) multi-sensor wearable device that uses AI. The device is currently involved in five clinical trials across the world. “We’re a young company that has been in stealth mode for almost three years working on this problem,” John Trobough, chairman and CEO of LifePlus, told MD+DI. “LifePlus is a company that has been focused on the application of machine learning and how we break down the problem of blood glucose and noninvasively measure that using commercial off the shelf hardware.” LifeLeaf resembles a smart watch and in addition to blood glucose monitoring, the multi-sensor device has the potential to non-invasively monitor heart rate, blood pressure, and respiration rate, and oxygen saturation. The firm described LifeLeaf as a “cloud-based AI solution with a user interface and connected mobile app that provides analytics with real-time notifications. Details about the technology emerged at the Medical Wearables Conference in Santa Clara, CA, being held this week. Market Big Enough For All Although LifePlus finds itself nestled in several different markets, the company could face stiff competition from two juggernauts in the industry ...
Source: MDDI - Category: Medical Devices Authors: Tags: Software Source Type: news